Motif Neurotech received FDA approval to begin a feasibility trial for their device, which uses an implanted brain stimulator activated by wearing a hat to treat treatment-resistant depression. This development offers tech professionals and developers insights into the integration of wearable technology with medical implants for mental health treatments. Next, watch for advancements in user interface designs that enhance patient interaction with such devices.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



